Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 9—September 2008

Crack Cocaine and Infectious Tuberculosis

Alistair StoryComments to Author , Graham Bothamley, and Andrew Hayward
Author affiliations: Health Protection Agency, London, UK (A. Story); Homerton Hospitals National Health Service Foundation Trust, London (G. Bothamley); University College London Centre for Infectious Disease Epidemiology, London (A. Hayward)

Main Article

Table 2

Multivariate analysis of risk factors for smear-positive disease on diagnosis among drug-using and non–drug-using patients with pulmonary TB in London, UK, 2003–2004*

Variable OR 95% CI p value
Not a hard-drug user Baseline
Hard-drug user (not known to use crack cocaine) 1.87 1.19–2.95 0.007
Crack cocaine user
Age, y
0–14 0.10 0.08–0.56 0.002
15–29 1.10 0.81–1.48 0.55
30–59 Baseline
South Asian Baseline
Black African 1.75 0.96–1.95 0.08
White 1.51 0.99–2.31 0.053
Black Caribbean 2.70 1.34–5.43 0.005
Other ethnicity
No drug resistance Baseline
INH (not outbreak strain) 1.23 0.72–2.11 0.441
INH (outbreak strain) 0.96 0.37–2.50 0.929
MDR 2.90 1.44–5.78 0.003
Sought treatment at ED 3.33 2.20–4.82 <0.001

*OR, odds ratio; CI, confidence interval; INH, isoniazid resistant; MDR, multidrug-resistant; ED, emergency department.

Main Article

Page created: July 13, 2010
Page updated: July 13, 2010
Page reviewed: July 13, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.